MedTrace Logo

Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTEâ„¢ Transcarotid Neuroprotection System

NCT07455747 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-05-18

No results posted yet for this study

Summary

The ENTRUST registry's objective is to collect real-world data (RWD) and health economic data on the ENROUTEâ„¢ Transcarotid Neuroprotection System (ENROUTEâ„¢ Transcarotid NPS), including populations in which outcomes of TCAR in patients with extracranial carotid artery disease are inadequately reported.

Conditions

  • Extracranial Carotid Artery Disease
  • TCAR
  • Transcarotid Artery Revascularization

Interventions

DEVICE

Use of ENROUTEâ„¢ Transcarotid Neuroprotection System in conjunction with any commercially available Boston Scientific stent marketed for treatment of carotid artery disease

ENROUTEâ„¢ Transcarotid NPS AND ENROUTEâ„¢ Transcarotid Stent System. Additionally, ENROUTEâ„¢ Transcarotid NPS AND any commercially available Boston Scientific stent marketed for treatment of carotid artery disease may be added upon commercial availability.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Angela H Martin, MD · Evansville Surgical Associates

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2028-05-31
Completion
2030-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07455747 on ClinicalTrials.gov